INS and obesity disorder: Furthermore, it has been suggested that long-term selenium supplementation at high doses may increase the risk of obesity and diabetes by maintaining excessive GPx1 activity that may alter the physiological inhibition mechanism of PTP1B resulting in permanent inhibition of insulin signalling and activation of the lipogenic pathway [24-26].